1. Home
  2. QTRX vs SCD Comparison

QTRX vs SCD Comparison

Compare QTRX & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • SCD
  • Stock Information
  • Founded
  • QTRX 2007
  • SCD 2003
  • Country
  • QTRX United States
  • SCD United States
  • Employees
  • QTRX N/A
  • SCD N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • QTRX Industrials
  • SCD Finance
  • Exchange
  • QTRX Nasdaq
  • SCD Nasdaq
  • Market Cap
  • QTRX 233.5M
  • SCD 272.7M
  • IPO Year
  • QTRX 2017
  • SCD N/A
  • Fundamental
  • Price
  • QTRX $6.12
  • SCD $15.22
  • Analyst Decision
  • QTRX Buy
  • SCD
  • Analyst Count
  • QTRX 5
  • SCD 0
  • Target Price
  • QTRX $15.60
  • SCD N/A
  • AVG Volume (30 Days)
  • QTRX 763.5K
  • SCD 62.6K
  • Earning Date
  • QTRX 08-07-2025
  • SCD 01-01-0001
  • Dividend Yield
  • QTRX N/A
  • SCD 9.63%
  • EPS Growth
  • QTRX N/A
  • SCD N/A
  • EPS
  • QTRX N/A
  • SCD N/A
  • Revenue
  • QTRX $135,688,000.00
  • SCD N/A
  • Revenue This Year
  • QTRX N/A
  • SCD N/A
  • Revenue Next Year
  • QTRX $14.49
  • SCD N/A
  • P/E Ratio
  • QTRX N/A
  • SCD N/A
  • Revenue Growth
  • QTRX 7.71
  • SCD N/A
  • 52 Week Low
  • QTRX $4.05
  • SCD $11.33
  • 52 Week High
  • QTRX $16.74
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 55.97
  • SCD 39.16
  • Support Level
  • QTRX $5.98
  • SCD $15.46
  • Resistance Level
  • QTRX $6.76
  • SCD $16.02
  • Average True Range (ATR)
  • QTRX 0.52
  • SCD 0.37
  • MACD
  • QTRX 0.09
  • SCD -0.15
  • Stochastic Oscillator
  • QTRX 56.46
  • SCD 0.60

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

Share on Social Networks: